{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:23:42Z","timestamp":1784903022772,"version":"3.55.0"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,24]]},"abstract":"<jats:p>We present the case of a patient with acrodermatitis continua of Hallopeau (ACH) who was resistant to traditional therapies such as acitretin, ciclosporin and methotrexate, as well as secukinumab and ustekinumab, who was successfully treated with subcutaneous spesolimab, resulting in rapid resolution of skin lesions.<\/jats:p>","DOI":"10.1093\/ced\/llae443","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T16:35:04Z","timestamp":1729614904000},"page":"668-669","source":"Crossref","is-referenced-by-count":2,"title":["Rapid improvement in refractory acrodermatitis continua of Hallopeau with spesolimab injection"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8703-5756","authenticated-orcid":false,"given":"Yong","family":"He","sequence":"first","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshu","family":"Xiong","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5047-5341","authenticated-orcid":false,"given":"Haoxiang","family":"Xu","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"2025022416241493700_llae443-B1","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/jdv.14386","article-title":"European consensus statement on phenotypes of pustular psoriasis","volume":"31","author":"Navarini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025022416241493700_llae443-B2","first-page":"65","article-title":"Acrodermatitis continua of\u00a0Hallopeau: clinical perspectives","volume":"9","author":"Smith","year":"2019","journal-title":"Psoriasis (Auckl)"},{"key":"2025022416241493700_llae443-B3","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3390\/biomedicines9121746","article-title":"Pustular psoriasis: from pathophysiology to treatment","volume":"9","author":"Genovese","year":"2021","journal-title":"Biomedicines"},{"key":"2025022416241493700_llae443-B4","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s40265-022-01801-4","article-title":"Spesolimab: first approval","volume":"82","author":"Blair","year":"2022","journal-title":"Drugs"},{"key":"2025022416241493700_llae443-B5","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/exd.14805","article-title":"Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: should they be the same or different entities?","volume":"32","author":"Chularojanamontri","year":"2023","journal-title":"Exp Dermatol"},{"key":"2025022416241493700_llae443-B6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamadermatol.2023.6349","article-title":"Spesolimab response in a girl with acrodermatitis continua of Hallopeau","volume":"160","author":"Wang","year":"2024","journal-title":"JAMA Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae443\/60934978\/llae443.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/3\/668\/60934978\/llae443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/3\/668\/60934978\/llae443.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T16:24:38Z","timestamp":1740414278000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/3\/668\/7831331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":6,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,10,22]]},"published-print":{"date-parts":[[2025,2,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae443","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,10,22]]}}}